Updates are available Correction dated 2023-05-17
Click to view Correction: https://doi.org/10.1186/s13046-023-02709-x
-
Authors
Cigliano, Antonio
Zhang, Shanshan
Ribback, Silvia
Steinmann, Sara
Sini, Marcella
Ament, Cindy E.
Utpatel, Kirsten
Song, Xinhua
Wang, Jingxiao
Pilo, Maria G.
Berger, Fabian
Wang, Haichuan
Tao, Junyan
Li, Xiaolei
Pes, Giovanni M.
Mancarella, Serena
Giannelli, Gianluigi
Dombrowski, Frank
Evert, Matthias
Calvisi, Diego F.
Chen, Xin
Evert, Katja
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA190606)
Liver Center, University of California, San Francisco (P30DK026743)
Associazione Italiana per la Ricerca sul Cancro (24815)
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 5 March 2022
Accepted: 16 May 2022
First Online: 3 June 2022
Change Date: 17 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13046-023-02709-x
Declarations
:
: Not applicable.
: Mice were maintained and monitored following protocols approved by the Committee for Animal Research at the University of California, San Francisco (San Francisco, CA).Human iCCA samples were collected at the Universities of Greifswald (Greifswald, Germany) and Regensburg (Regensburg, Germany). Institutional Review Board approval was provided by the local Ethical Committees of the Medical University of Greifswald and Regensburg (approval # BB 67/10 and 17–1015-101, respectively) in compliance with the Helsinki Declaration. Informed consent was obtained from all individuals. Clinicopathological characteristics of patients are summarized in Supplementary Table .
: The authors declare that they have no competing interests.
